Ann: IHL-42x (OSA) accelerated FDA approval pathway, page-67

First 67 Last

Share
Profile

Follow
dalts66

4,336 Posts.

2023

05/09/20

08:41

Post #: 47107943
Share

Originally posted by MickeyMantle536: ↑

I’ve been quiet on the thread but buying.

The ASX has fallen 39% from its peak and currently down 34%. Some banks have fallen nearly 60%, less than IHL.

At these prices you are paying sub $20m EV for a Company that has not changed, in fact it’s improved. The trials have not been pushed back and the oil sales are ramping up. IMO the selling has been either fear based or a necessity of someone’s personal financial situation. There’s $5 million in the bank and a big year ahead of news. The last announcement tells you how advanced the program is and it’s been pulled apart and evaluated by one of the best consultants in the business, Camargo Pharmaceutical Services. This is a “turn your head and cough” look under the bonnet for the OSA program.

There is so much negative news priced into this market, everyone expects a shutdown, recession and low interest rates for the foreseeable future. There’s no positive press (the press have been diabolical IMO). What happens when we start seeing something positive?

Sentiment changes quickly in the market and the market turns before you read about in the SMH!

Expand

In this one Mickey, if you go through the thread, you even state the trials havent been pushed back. But they were, and already had been.
This is what i was referring to when I stated the BOD need to learn how important it is to clearly state timelines. Investor deserve clear guidnace on where the company is going so they can make unemotional investment decisions.
4 Upvote

1 Great analysis

Reply

Top Stories

RHK

Red Hawk upgrades Blacksmith with DSO mineral resource at the Eagle Deposit

MIN

MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned

Nine's staff strike as Paris Olympic coverage begins

MND

Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?

NVA

Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter